[{"data":1,"prerenderedAt":153},["ShallowReactive",2],{"compound-bpc-tb-500":3,"compound-related-bpc-tb-500":130,"compound-reading-bpc-tb-500":144},{"id":4,"title":5,"alsoKnownAs":6,"body":7,"casNumber":101,"category":102,"description":93,"extension":103,"faq":104,"meta":111,"molecularFormula":101,"molecularWeight":101,"name":112,"navigation":113,"path":114,"presentations":115,"purity":118,"rank":119,"relatedCompounds":120,"relatedResearch":123,"seo":126,"sequence":101,"stem":127,"summary":128,"__hash__":129},"compounds\u002Fcompounds\u002Fbpc-tb-500.md","BPC-157 & TB-500 Blend","Repair blend",{"type":8,"value":9,"toc":92},"minimark",[10,15,19,22,26,29,36,42,45,48,52,58,67,70,74,77,85,89],[11,12,14],"h2",{"id":13},"what-this-is","What this is",[16,17,18],"p",{},"A single vial containing both BPC-157 and thymosin β4 (TB-500) in a fixed ratio,\nlyophilised together. The two compounds appear together frequently enough in\ntissue repair research that a combined preparation removes a step: one\nreconstitution, one vial, a ratio that does not depend on pipetting.",[16,20,21],{},"Neither compound is altered by being blended. BPC-157 remains the 15-residue\ngastric-juice-derived sequence; thymosin β4 remains the 43-residue\nactin-sequestering peptide. What changes is the format.",[11,23,25],{"id":24},"why-these-two-together","Why these two together",[16,27,28],{},"The two compounds are studied against overlapping endpoints from\nnon-overlapping mechanisms, which is the usual justification for pairing them.",[16,30,31,35],{},[32,33,34],"strong",{},"Thymosin β4"," acts on actin monomer availability and therefore on cell\nmigration — the mechanical prerequisite for a cell population moving into a\nwound bed.",[16,37,38,41],{},[32,39,40],{},"BPC-157"," is studied for effects on angiogenesis and growth factor receptor\nexpression, with a recurring nitric oxide pathway theme — the vascular and\nsignalling side of the same process.",[16,43,44],{},"Whether the combination produces more than the sum of its parts is an open\nresearch question rather than an established finding, and it is worth stating\nthat plainly: the pairing is common in the literature because the mechanisms are\ncomplementary in principle, not because synergy has been demonstrated.",[16,46,47],{},"Supplied for in-vitro laboratory research only. No therapeutic claim is made and\nno dosing or administration guidance is provided.",[11,49,51],{"id":50},"analytical-notes","Analytical notes",[16,53,54,57],{},[32,55,56],{},"A blend needs a certificate per component, not per vial."," Each compound is\nanalysed as its own material — its own HPLC purity figure, its own mass\nspectrometry identity confirmation — before the two are combined. The batch\ncertificate reports both.",[16,59,60,61,66],{},"Be suspicious of blend certificates that quote a single purity percentage. A\nchromatogram of a two-component blend has two main peaks. \"99.3%\" cannot describe\nboth of them, and the number is either describing one component while ignoring\nthe other, or it was never derived from a chromatogram at all. See\n",[62,63,65],"a",{"href":64},"\u002Fresearch\u002Fspotting-a-fabricated-coa","spotting a fabricated COA",".",[16,68,69],{},"The second question a blend certificate should answer is the ratio, since the\nstated masses are what determine the concentration of each component after\nreconstitution.",[11,71,73],{"id":72},"handling-and-storage","Handling and storage",[16,75,76],{},"Store sealed at −20 °C, protected from light and moisture. Bring to room\ntemperature before opening, reconstitute by running diluent down the vial wall,\nand swirl rather than shake. Store solution at 2–8 °C, protected from light.",[16,78,79,80,84],{},"Note that reconstituting a blend gives you two concentrations from one volume:\neach component's concentration is its own mass divided by the diluent volume. The\n",[62,81,83],{"href":82},"\u002Ftools\u002Freconstitution-calculator","reconstitution calculator"," handles each\ncomponent separately — run it twice.",[11,86,88],{"id":87},"what-we-supply","What we supply",[16,90,91],{},"Both components released against a ≥99% purity specification individually, with\nper-component HPLC and mass spectrometry results recorded on a single\nbatch-specific Certificate of Analysis. Select batches additionally receive\nindependent third-party purity verification.",{"title":93,"searchDepth":94,"depth":94,"links":95},"",2,[96,97,98,99,100],{"id":13,"depth":94,"text":14},{"id":24,"depth":94,"text":25},{"id":50,"depth":94,"text":51},{"id":72,"depth":94,"text":73},{"id":87,"depth":94,"text":88},null,"Blends","md",[105,108],{"question":106,"answer":107},"How is a blend analysed differently from a single compound?","Each component is analysed as its own material before blending, and each gets its own purity figure and mass confirmation. A blend certificate reporting a single combined purity percentage is not meaningful — two components produce two main peaks, and a single number cannot describe both.",{"question":109,"answer":110},"Why buy a blend rather than two vials?","One reconstitution instead of two, and a fixed ratio that does not depend on pipetting accuracy at the bench. The trade-off is that the ratio is set at the point of filling and cannot be varied afterwards, so separate vials remain the better choice for any work where the ratio is a variable.",{},"BPC-157 + TB-500",true,"\u002Fcompounds\u002Fbpc-tb-500",[116,117],"5 mg + 5 mg vial","10 mg + 10 mg vial","≥99% per component",12,[121,122],"bpc-157","tb-500",[124,125],"how-to-read-a-peptide-coa","net-peptide-content-vs-purity",{"title":5,"description":93},"compounds\u002Fbpc-tb-500","A combined preparation of BPC-157 and thymosin β4, used where both compounds are required in a single reconstitution.","rLkZw90Sr8o-7uWQWMIrpnwtPQNu_bz-Wj76JQ1UrOY",[131,138],{"path":132,"name":40,"alsoKnownAs":133,"summary":134,"category":135,"molecularWeight":136,"purity":137},"\u002Fcompounds\u002Fbpc-157","Body Protection Compound 157 · PL 14736","A synthetic 15-amino-acid sequence derived from human gastric juice protein BPC, studied extensively in tissue repair and angiogenesis models.","Repair & Recovery","~1,419.5 Da","≥99%",{"path":139,"name":140,"alsoKnownAs":141,"summary":142,"category":135,"molecularWeight":143,"purity":137},"\u002Fcompounds\u002Ftb-500","TB-500","Thymosin β4 · Tβ4","A synthetic form of thymosin beta-4, the principal actin-sequestering peptide in mammalian cells, studied in cell migration and tissue repair models.","~4,963 Da",[145,149],{"path":146,"title":147,"description":148},"\u002Fresearch\u002Fhow-to-read-a-peptide-coa","How to Read a Peptide Certificate of Analysis","A field-by-field walkthrough of a peptide COA — what each number establishes, which fields are load-bearing, and what a missing batch number tells you about the rest of the document.",{"path":150,"title":151,"description":152},"\u002Fresearch\u002Fnet-peptide-content-vs-purity","Net Peptide Content vs Purity: The Two Numbers Everyone Confuses","A vial can be 99% pure and still contain 25% less peptide than the label says. Why purity and net peptide content are different measurements, and which one your concentration calculation actually needs.",1787473952615]